Old Web
English
Sign In
Acemap
>
authorDetail
>
Mike Ru Sung
Mike Ru Sung
University of Toronto
PD-L1
Pathology
Medicine
Cancer research
immune checkpoint inhibitors
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Myeloid immunosuppressive state as a predictor of rapidly progressive phenotype and poor survival in advanced non-small cell lung cancer (NSCLC) patients treated with PD-1/PD-L1 inhibitors.
2019
Journal of Clinical Oncology
Sally Cm Lau
Lisa W. Le
Sze Wah Samuel Chan
Elliot Charles Smith
Malcolm Ryan
M. Catherine Brown
Katrina Hueniken
Lawson Eng
Devalben Patel
Ruiqi Chen
Alona Zer
Mike Ru Sung
Penelope Ann Bradbury
Pamela S. Ohashi
Frances A. Shepherd
Ming-Sound Tsao
Natasha B. Leighl
Geoffrey Liu
Adrian G. Sacher
Show All
Source
Cite
Save
Citations (0)
Bone metastases as predictors of treatment response and rapidly progressive disease in NSCLC patients on PD-1/PD-L1 immune checkpoint inhibitors (ICI).
2019
Journal of Clinical Oncology
Sally Cm Lau
Lisa W. Le
Elliot Charles Smith
Sze Wah Samuel Chan
Malcolm Ryan
M. Catherine Brown
Katrina Hueniken
Lawson Eng
Devalben Patel
Ruiqi Chen
Mike Ru Sung
Alona Zer
Penelope Ann Bradbury
Pamela S. Ohashi
Frances A. Shepherd
Ming-Sound Tsao
Geoffrey Liu
Natasha B. Leighl
Adrian G. Sacher
Show All
Source
Cite
Save
Citations (1)
1